BioCentury
ARTICLE | Company News

Biovitrum, Synphora deal

October 16, 2006 7:00 AM UTC

BVT will provide Synphora with up to SEK5 million ($670,000) to help fund an ongoing Phase I trial of Synphora's JB991 for psoriasis and a potential Phase II trial. Synphora will remain fully respons...